Literature DB >> 9222361

The development of animal model systems for HIV-1 encephalitis and its associated dementia.

Y Persidsky1, H S Nottet, V G Sasseville, L G Epstein, H E Gendelman.   

Abstract

The human immunodeficiency virus (HIV) is neuroinvasive and can be neurovirulent. Indeed, 20-30% of individuals with the acquired immune deficiency syndrome (AIDS) develop cognitive and motor dysfunction (termed the AIDS dementia complex or HIV dementia) coincident with advanced immunosuppression. Despite massive research efforts to discern viral neuropathogenic mechanisms, much remains incompletely understood. Recently, we and others developed animal model systems to elucidate how HIV infection within the brain can lead to impairment of central nervous system function. In this report, we evaluate each of the published animal models for their ability to mirror HIV dementia. Ease of handling and expense were also under consideration. Ultimately, studies in animal systems should permit a better understanding of the nature of HIV-1-induced neurological injury and aid in the development of effective treatments for this dreaded complication of HIV infection.

Entities:  

Mesh:

Year:  1995        PMID: 9222361     DOI: 10.3109/13550289509114019

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  17 in total

1.  Characterization of an in vitro rhesus macaque blood-brain barrier.

Authors:  Andrew G MacLean; Marlene S Orandle; John MacKey; Kenneth C Williams; Xavier Alvarez; Andrew A Lackner
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

2.  Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.

Authors:  Suad Kapetanovic; Erin Leister; Sharon Nichols; Tracie Miller; Katherine Tassiopoulos; Rohan Hazra; Harris A Gelbard; Kathleen M Malee; Betsy Kammerer; Armando J Mendez; Paige L Williams
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

Review 3.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

4.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

5.  Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis.

Authors:  V G Sasseville; M M Smith; C R Mackay; D R Pauley; K G Mansfield; D J Ringler; A A Lackner
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

6.  Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV.

Authors:  Vanessa Rivera-Amill; Richard J Noel; Suheydi Orsini; Griselle Tirado; José M García; Shilpa Buch; Anil Kumar
Journal:  Virology       Date:  2006-09-28       Impact factor: 3.616

Review 7.  In vivo modeling of HIV-1 mediated neurodegeneration.

Authors:  E Masliah
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

8.  Human immunodeficiency virus encephalitis in SCID mice.

Authors:  Y Persidsky; J Limoges; R McComb; P Bock; T Baldwin; W Tyor; A Patil; H S Nottet; L Epstein; H Gelbard; E Flanagan; J Reinhard; S J Pirruccello; H E Gendelman
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

9.  Human microglial cell isolation from adult autopsy brain: brain pH, regional variation, and infection with human immunodeficiency virus type 1.

Authors:  Kimberly Schuenke; Benjamin B Gelman
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

10.  Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques.

Authors:  S Sopper; U Sauer; S Hemm; M Demuth; J Müller; C Stahl-Hennig; G Hunsmann; V ter Meulen; R Dörries
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.